What is the debt of Altimmune this year?
Altimmune has a debt level of -36.93 USD this year.
Altimmune Debt 2025
Altimmune Debt
-36.93 USD
Ticker
ALT
ISIN
US02155H2004
WKN
A2N5Z6
In 2025, Altimmune's total debt was -36.93 USD, a -72.67% change from the -135.12 USD total debt recorded in the previous year.
Altimmune Aktienanalyse
What does Altimmune do?
Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Altimmune's Debt Structure
Altimmune's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Altimmune's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Altimmune’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Altimmune’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Altimmune stock
What was the debt of Altimmune compared to the previous year?
The debt of Altimmune has increased by -72.67% compared to the previous year dropped.
What are the consequences of high debt for investors in Altimmune?
High debt can pose a risk for investors of Altimmune, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Altimmune?
Low debt means that Altimmune has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Altimmune affect the company?
An increase in debt of Altimmune can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Altimmune affect the company?
A reduction in debt of Altimmune can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Altimmune?
Some factors that can influence the debt of Altimmune include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Altimmune so important for investors?
The debts of Altimmune are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Altimmune take to change the debt?
To change the debt, Altimmune can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Altimmune pay?
Over the past 12 months, Altimmune paid a dividend of 873 USD . This corresponds to a dividend yield of about 15,617.17 %. For the coming 12 months, Altimmune is expected to pay a dividend of 0 USD.
What is the dividend yield of Altimmune?
The current dividend yield of Altimmune is 15,617.17 %.
When does Altimmune pay dividends?
Altimmune pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Altimmune?
Altimmune paid dividends every year for the past 0 years.
What is the dividend of Altimmune?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Altimmune located?
Altimmune is assigned to the 'Health' sector.
Wann musste ich die Aktien von Altimmune kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Altimmune from 2/3/2017 amounting to 2.91 USD, you needed to have the stock in your portfolio before the ex-date on 2/6/2017.
When did Altimmune pay the last dividend?
The last dividend was paid out on 2/3/2017.
What was the dividend of Altimmune in the year 2024?
In the year 2024, Altimmune distributed 0 USD as dividends.
In which currency does Altimmune pay out the dividend?
The dividends of Altimmune are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Altimmune
Our stock analysis for Altimmune Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Altimmune Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
